The injectable HIV prevention treatment Yetzugo, made by Gilead Sciences, has received FDA approval, offering a twice-yearly alternative to daily medications.

A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...

I experienced one of the most challenging episodes of my life.  I had just arrived home from work when the son of a close ...

Now, what if you add that you are HIV-positive into that mix? Nearly impossible, right? Well, Mandisa Dukashe was not only able to overcome her HIV-positive status and find love, but she's also able ...

Researchers at UCLA have recently announced that the first case of a woman with HIV in the U.S. has reached a state of remission. This is a result of what doctors call stem cell transplants. If she ...